郑州微飒生物科技有限责任公司 咨询热线:0371-88821766
行业动态

行业动态

追踪行业前沿,洞察产业趋势

药效评价Amyloid beta 42 peptide (Abeta42)-lowering compounds directly bind to Abeta and interfere with amyloid precursor protein (APP) transmembrane dimerization.

期刊:Proceedings of the National Academy of Sciences of the United States of America发表年份:2010作者:Luise Richter; Lisa-Marie Munter; Julia Ness; Peter W Hildebrand; Muralidhar Dasari; Stephanie Unterreitmeier; Bruno Bulic; Michael Beyermann; Ronald Gust; Bernd Reif; Sascha Weggen; Dieter Langosch; Gerd Multhaup

药效评价From anti-allergic to anti-Alzheimer's: Molecular pharmacology of Dimebon.

期刊:Current Alzheimer research发表年份:2010作者:I Okun; S E Tkachenko; A Khvat; O Mitkin; V Kazey; A V Ivachtchenko

药效评价L-stepholidine reduced L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease.

期刊:Neurobiology of aging发表年份:2010作者:Jiao Mo; Hai Zhang; Lei-Ping Yu; Pei-Hua Sun; Guo-Zhang Jin; Xuechu Zhen

药效评价AF-353, a novel, potent and orally bioavailable P2X3/P2X2/3 receptor antagonist.

期刊:British journal of pharmacology发表年份:2010作者:Joel R Gever; Rothschild Soto; Robert A Henningsen; Renee S Martin; David H Hackos; Sandip Panicker; Werner Rubas; Ian B Oglesby; Michael P Dillon; Marcos E Milla; Geoffrey Burnstock; Anthony P D W Ford